These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 1708055

  • 1. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
    Barrett RJ, Appell KC, Kilpatrick BF, Proakis AG, Nolan JC, Walsh DA.
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive rats.
    Barrett RJ, Wright KF, Allen AD, Taylor DR.
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):134-44. PubMed ID: 1708047
    [Abstract] [Full Text] [Related]

  • 3. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF, Gleason MM, Hedberg A, Shank RP, McCullough JR, Gill A, Damiano BP, Brannan MD, Carson JR.
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [Abstract] [Full Text] [Related]

  • 4. Gamma-mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist.
    Chairungsrilerd N, Furukawa KI, Ohta T, Nozoe S, Ohizumi Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):25-31. PubMed ID: 9459569
    [Abstract] [Full Text] [Related]

  • 5. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP, Chiu CC, Chen SJ, Chen IJ, Wu BN.
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T, Sugidachi A, Tanaka N, Fujimoto K, Asai F.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):107-14. PubMed ID: 12464356
    [Abstract] [Full Text] [Related]

  • 7. [The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].
    Fujishima Y, Hara H, Shimazawa M, Yokota K, Sukamoto T.
    Nihon Yakurigaku Zasshi; 1994 Jul 20; 104(1):19-29. PubMed ID: 8076888
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.
    Anderson WG, Kam ST.
    Br J Pharmacol; 1985 Apr 20; 84(4):793-800. PubMed ID: 2860940
    [Abstract] [Full Text] [Related]

  • 9. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
    Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautret B, Neliat G, Labeeuw B, Le Fur G, Soubrie P, Breliere JC.
    J Pharmacol Exp Ther; 1992 Aug 20; 262(2):759-68. PubMed ID: 1501121
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R, Tulp MT, Menge WM, Adolfs MJ, Zuiderveld OP, Timmerman H.
    Br J Pharmacol; 1995 Oct 20; 116(4):2315-21. PubMed ID: 8564266
    [Abstract] [Full Text] [Related]

  • 11. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
    Eglen RM, Bley K, Bonhaus DW, Clark RD, Hegde SS, Johnson LG, Leung E, Wong EH.
    Br J Pharmacol; 1993 Sep 20; 110(1):119-26. PubMed ID: 8220871
    [Abstract] [Full Text] [Related]

  • 12. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E, Rizzi CA, Candura SM, Lucchelli A, Balestra B, Tonini M.
    Br J Pharmacol; 1995 Jun 20; 115(4):677-83. PubMed ID: 7582490
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML, Fuller RW, Kurz KD, Parli CJ, Mason NR, Meyers DB, Smallwood JK, Toomey RE.
    J Pharmacol Exp Ther; 1988 Jan 20; 244(1):106-12. PubMed ID: 3335993
    [Abstract] [Full Text] [Related]

  • 17. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC, Gunthorpe MJ, Taylor CW, Lummis SC.
    Mol Pharmacol; 1996 Nov 20; 50(5):1284-94. PubMed ID: 8913360
    [Abstract] [Full Text] [Related]

  • 18. Skimmianine and related furoquinolines function as antagonists of 5-hydroxytryptamine receptors in animals.
    Cheng JT, Chang TK, Chen IS.
    J Auton Pharmacol; 1994 Oct 20; 14(5):365-74. PubMed ID: 7829541
    [Abstract] [Full Text] [Related]

  • 19. Differential vasomotor action of noradrenaline, serotonin, and histamine in isolated basilar artery from rat and guinea-pig.
    Chang JY, Hardebo JE, Owman C.
    Acta Physiol Scand; 1988 Jan 20; 132(1):91-102. PubMed ID: 2906211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.